Biotechnology Acquisitions in South Dakota
Showing 1 transactions.
-
October 20, 2021
- Buyer
- Big Cypress Acquisition Corp.
- Target
- SAB Biotherapeutics, Inc.
- Industry
- Biotechnology
- Location
- South Dakota, United States
- Type
- Buyout
Big Cypress Acquisition Corp., a Nasdaq-listed special purpose acquisition company, received shareholder approval to complete a business combination with clinical-stage biopharmaceutical company SAB Biotherapeutics. Upon closing, the combined company will be named SAB Biotherapeutics, Inc. and its common stock and warrants are expected to trade on Nasdaq, providing SAB with public-market capital to advance its antibody immunotherapy platform and clinical programs.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.